Answers are grounded in this paper and cite their sources.
It's a rap: A double recombination strategy has been utilized to uncover the biosynthetic route to the key intermediate in the formation of rapamycin. Removal of a section of the rapamycin gene cluster from Streptomyces hygroscopicus produced a strain that generated no rapamycin. Gene complementation proved, surprisingly, that the accumulation of this previously elusive intermediate pre-rapamycin (1) depended on the presence of the gene rapK.
No takes yet. Share an insight, caveat, or question.
Gregory et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: